| Drug Name |
Carbenicillin indanyl sodium |
| Drug ID |
BADD_D00358 |
| Description |
Carindacillin or Carbenicillin isdanyl was an oral penicillin prodrug of [carbenicillin] marketed by Pfizer as Geocillin. It is no longer marketed in the United States. |
| Indications and Usage |
For the treatment of acute and chronic infections of the upper and lower urinary tract and in asymptomatic bacteriuria (due to susceptible strains Escherichia coli, Proteus mirabilis, Morganella morganii, Providencia rettgeri, Proteus vulgaris, Pseudomonas, Enterobacter, and Enterococci.). Also indicated in the treatment of prostatitis (due to susceptible strains Escherichia coli Enterococcus (S. faecalis), Proteus mirabilis Enterobacter sp.). |
| Marketing Status |
approved; investigational |
| ATC Code |
J01CA05 |
| DrugBank ID |
DB09319
|
| KEGG ID |
D01283
|
| MeSH ID |
C100244
|
| PubChem ID |
23676503
|
| TTD Drug ID |
D0PN1F
|
| NDC Product Code |
Not Available |
| UNII |
4OUL81K2RT
|
| Synonyms |
carbenicillin indanyl | indanyl carbenicillin | N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamate | carindacillin | carbenicillin indanyl, 2S-(2alpha,5alpha,6beta)-isomer | Geocillin | CP 15,464-2 | CP-15,464-2 | CP 15464 | CP-15464 | carbenicillin indanyl sodium | carindacillin sodium | sodium carindacillin | Carindapen |
